Drug
Selonsertib
Selonsertib: highest development phase Phase 1, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Selonsertib NCT02509624 | Phase 1 | Diabetic Kidney Disease |
Latest
No recent events.
Follow Selonsertib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.